Tag: affymetrix
January 3, 2018
ChroMedX Corp. Executes Definitive Agreement with DxEconomix to Lead Value-Based Transactions
ChroMedX Corp. (CSE:CHX) (OTC:CHXIF) (FSE: EIY2), (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to report...
November 27, 2017
ChroMedX Accepts Proposal; Signs LOI with Diagnostic Marketing Experts to Conduct a Value-Based Transaction for the HemoPalm Blood Analyzer System
ChroMedX Corp. (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company“), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to...
November 24, 2017
ChroMedX Agrees Have DxEconmix Promote HemoPalm
ChroMedX Corp. (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company“), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to...
November 30, 2016
Is the Stem Cell Market Heating Up? Acquisition Activity Suggests Yes.
Stem cell research seems to be heating up—a hypothesis further evidenced by 2016's acquisition activity. May 10, 2016
Technavio Expects the Global Biochips Market to Exceed USD 13 Billion by 2020
LONDON–(BUSINESS WIRE)–According to the latest market study released by Technavio, the global biochips market is expected to exceed USD 13...
September 8, 2015